Corporate Connect Research has provided updated coverage on BluGlass Limited (ASX:BLG) following the Company’s Q3 results, announcement of the Company’s US$90-100m project pipeline, placement and SPP.
The report highlights:
The full report is available to download here: Corporate Connect Research BLG update final
Developing leading-edge semiconductor manufacturing technology and devices for more than a decade, BluGlass Limited (ASX:BLG) is a leading supplier of GaN laser diode products to the global photonics industry, focused on the industrial, defence, bio-medical, and scientific markets.
Listed on the ASX, BluGlass is one of just a handful of end-to-end GaN laser manufacturers globally. Its operations in Australia and the USA offer cutting-edge, custom laser diode development and manufacturing, from small-batch custom lasers to medium and high-volume off-the-shelf products.
The Company combines its proprietary low temperature, low hydrogen, remote plasma chemical vapour deposition (RPCVD) manufacturing process with advanced device design and fabrication to deliver differentiated laser solutions. With end-to-end capabilities spanning epitaxy, device design, fabrication, and testing, BluGlass is well-positioned to support critical next-generation photonics applications and sovereign supply chains.
For more information, please contact:
Stefanie Winwood
+61293342300 |swinwood@bluglass.com
Jasmine Walters, Automic Markets
+61498209019 |jasmine.walters@automicgroup.com.au
Samuel Samhan, BluGlass CFO
ssamhan@bluglass.com
